Polymer particles

US9803043B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9803043-B2
Application numberUS-201615369213-A
CountryUS
Kind codeB2
Filing dateDec 5, 2016
Priority dateSep 19, 2013
Publication dateOct 31, 2017
Grant dateOct 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.

First claim

Opening claim text (preview).

We claim: 1. A polymer particle comprising: at least one monomer including at least one functional group; and at least one crosslinker; wherein the polymer particle has a spherical diameter between about 40 μm and about 1,200 μm and is susceptible to degradation through hydrolysis or enzymatic action, and wherein the degradation provides less than about 10% of the polymer particle intact after about 5 days. 2. The polymer particle of claim 1 , wherein the polymer particle has a spherical diameter between about 75 μm and about 1,200 μm. 3. The polymer particle of claim 1 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide. 4. The polymer particle of claim 1 , wherein the at least one monomer includes an ionizable functional group. 5. The polymer particle of claim 4 , wherein the ionizable functional group is basic or acidic. 6. The polymer particle of claim 1 , wherein the at least one crosslinker includes at least two functional groups. 7. The polymer particle of claim 1 , wherein the crosslinker includes at least one linkage susceptible to degradation through hydrolysis or enzymatic action. 8. The polymer particle of claim 7 , wherein the crosslinker is bis-glycidyl amino alcohol, wherein a, b, c, d, e, and f are each independently 1-20. 9. The polymer particle of claim 7 , wherein the at least one linkage is an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, a peptide cleavable by matrix cathepsins, or a combination thereof. 10. The polymer particle of claim 9 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins. 11. The polymer particle of claim 1 , wherein the at least one monomer is dimethylacrylamide and the at least one crosslinker is bis-glycidyl amino alcohol. 12. The polymer particle of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate. 13. A method of making a polymer particle comprising: reacting a prepolymer solution including at least one monomer including at least one functional group, at least one crosslinker susceptible to degradation through hydrolysis or enzymatic action, and an initiator in an oil; and forming the polymer particle, wherein the polymer particle has a spherical diameter between about 40 μm and about 1,200 μm, and wherein the degradation provides less than about 10% of the polymer particle intact after about 5 days. 14. The method of claim 13 , wherein the oil is mineral oil. 15. The method of claim 13 , wherein the initiator is N,N,N′,N′-tetramethylethylenediamine. 16. The method of claim 13 , wherein the polymer particle has a circularity of at least about 0.90. 17. The method of claim 13 , wherein the at least one crosslinker is bis-glycidyl amino alcohol, wherein a, b, c, d, e, and f are each independently 1-20. 18. The method of claim 13 , wherein the polymer particle is substantially degraded within about 6 months of implantation. 19. The method of claim 13 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bis-glycidyl amino alcohol. 20. The method of claim 13 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

Assignees

Inventors

Classifications

  • substituted imides comprising other heteroatoms · CPC title

  • Acrylamide; Methacrylamide · CPC title

  • Biodegradable · CPC title

  • Homopolymers or copolymers of acrylamide or methacrylamide · CPC title

  • Nitrogen-containing compounds {(C08K5/0091 takes precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9803043B2 cover?
Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.
Who is the assignee on this patent?
Terumo Corp
What technology area does this patent fall under?
Primary CPC classification C08J3/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).